265 related articles for article (PubMed ID: 28315612)
1. Ultrasound assessment of peripheral nerve pathology in neurofibromatosis type 1 and 2.
Winter N; Rattay TW; Axer H; Schäffer E; Décard BF; Gugel I; Schuhmann M; Grimm A
Clin Neurophysiol; 2017 May; 128(5):702-706. PubMed ID: 28315612
[TBL] [Abstract][Full Text] [Related]
2. Nerve ultrasound shows subclinical peripheral nerve involvement in neurofibromatosis type 2.
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Muscle Nerve; 2018 Feb; 57(2):312-316. PubMed ID: 28662276
[TBL] [Abstract][Full Text] [Related]
3. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
4. [Polyneuropathy associated with neurofibromatosis].
Drouet A; Créange A
Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
[TBL] [Abstract][Full Text] [Related]
5. Nerve ultrasound: A useful screening tool for peripheral nerve sheath tumors in NF1?
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Neurology; 2017 Apr; 88(17):1615-1622. PubMed ID: 28341644
[TBL] [Abstract][Full Text] [Related]
6. Nerve ultrasound in neurofibromatosis type 1: A follow-up study.
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Clin Neurophysiol; 2018 Feb; 129(2):354-359. PubMed ID: 29288991
[TBL] [Abstract][Full Text] [Related]
7. Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2.
Farschtschi S; Gelderblom M; Buschbaum S; Bostock H; Grafe P; Mautner VF
Muscle Nerve; 2017 Mar; 55(3):350-358. PubMed ID: 27422240
[TBL] [Abstract][Full Text] [Related]
8. [Seizures in neurofibromatosis. What is the risk?].
Drouet A
Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
[TBL] [Abstract][Full Text] [Related]
9. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Ahlawat S; Blakeley JO; Langmead S; Belzberg AJ; Fayad LM
Skeletal Radiol; 2020 Feb; 49(2):199-219. PubMed ID: 31396668
[TBL] [Abstract][Full Text] [Related]
10. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
[TBL] [Abstract][Full Text] [Related]
11. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
13. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study.
Bendon CL; Furniss D; Giele HP
J Plast Reconstr Aesthet Surg; 2015 Sep; 68(9):1199-203. PubMed ID: 26139580
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of neurofibromatosis in southern Brazil.
Rosset C; Vairo F; Cristina Bandeira I; Fonini M; Netto CBO; Ashton-Prolla P
Expert Rev Mol Diagn; 2018 Jun; 18(6):577-586. PubMed ID: 29685074
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
[TBL] [Abstract][Full Text] [Related]
17. Integrated imaging in peripheral nerve lesions in type 1 neurofibromatosis.
Iannicelli E; Rossi G; Almberger M; Drudi FM; Giustini S; Calvieri S; David V
Radiol Med; 2002 Apr; 103(4):332-43. PubMed ID: 12107383
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound of the peripheral nerves in systemic vasculitic neuropathies.
Grimm A; Décard BF; Bischof A; Axer H
J Neurol Sci; 2014 Dec; 347(1-2):44-9. PubMed ID: 25262016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
